Skip to content
AnalystLens

Omega Healthcare Investors Annual Report, Year Ended Dec 31, 2025

Filing Date
Filed February 9, 2026
Period End
December 31, 2025
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Jan ’25Jan ’25

Summary

Summary of the 10-K filed February 9, 2026. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. ("Parent") is a Maryland REIT that invests in healthcare-related real estate in the U.S., U.K. and Canada, with a portfolio of 1,027 operating healthcare facilities operated by 89 third-party operators or managers as of December 31, 2025.

Total revenues rose to $1.19 billiona in 2025 from $1.05 billion in 2024, net income was $609.5 million versus $417.8 million, and Nareit FFO was $898.9 million versus $733.9 million. Rental income increased to $1.00 billion and interest income to $175.1 million. Gains on assets sold were $67.3 million from the sale of 49 facilities for approximately $282.8 million in net cash proceeds.

The balance sheet grew to $10.05 billionb in total assets, with total debt of $4.3 billion and approximately 44.1% of total capitalization represented by debt. Cash and cash equivalents fell to $27.0 million from $518.3 million, and the company reported a weighted average debt interest rate of 4.2%. During 2025 the company issued $600 million of 5.200% senior notes due 2030, entered a $2.0 billion revolving credit facility and a $300.0 million 2028 Term Loan, redeemed $600.0 million of 5.250% notes, and sold 16.3 million shares under its ATM and DRCSPP programs for $612.1 million in gross proceeds.

Dividends paid were $2.68c per share in 2025, and a $0.67 dividend was declared on January 29, 2026. Key risks disclosed include operator financial stress tied to Medicaid and Medicare reimbursement, including the OBBBA's estimated $920 billion in Medicaid cuts over the next decade; operator bankruptcies, notably Genesis Healthcare (Chapter 11 since July 2025) and LaVie; and concentration, with the U.K. at 17.7% and Texas at 8.5% of real estate assets and mortgages.

Maplewood's cash-basis lease and restructured loan were also significant items. Ernst & Young issued unqualified opinions on the financial statements and internal control over financial reporting.

Key Highlights

  1. Total revenues of $1.19 billion in 2025, up from $1.05 billion in 2024; net income of $609.5 million versus $417.8 million in 2024.
  2. Nareit FFO of $898.9 million in 2025 compared with $733.9 million in 2024.
  3. Portfolio of 1,027 operating healthcare facilities across 42 states, Washington, D.C., the U.K. and Jersey, with total real estate assets of $9.63 billion (gross) and 88.5% of investments in real estate assets and mortgage loans.
  4. Acquired 71 facilities for $690.4 million and sold 49 facilities for approximately $282.8 million in net cash proceeds, with a net gain of approximately $67.3 million.
  5. Debt of $4.3 billion at a weighted average interest rate of 4.2%; $1.8 billion of revolver availability and cash of $27.0 million at December 31, 2025.
  6. Sold 16.3 million shares under ATM and DRCSPP programs for $612.1 million in gross proceeds; $2.0 billion of ATM capacity remaining.
  7. Operator risk remains elevated: 20 operator leases on a cash basis represented 19.0% of 2025 total revenues, and Genesis Healthcare is in Chapter 11 bankruptcy.

Financial Statements

FY2025 against FY2024

Line itemFY2025FY2024Change
Revenue$1.19B$1.05B+13.2%
Operating Expenses$688.02M$648.89M+6.0%
Interest Expense$215.03M$221.72M−3.0%
Net Income$609K$406.33M−99.9%
EPS (Basic)$1.96$1.57+24.8%
EPS (Diluted)$1.94$1.55+25.2%
Shares Outstanding (Basic)291.65M258.12M+13.0%
Shares Outstanding (Diluted)304.95M270.45M+12.8%

Frequently Asked Questions

  1. How did Omega's core earnings and cash generation trend in 2025?

    Nareit FFO rose to $898.9 million from $733.9 million, and net cash provided by operating activities increased to $878.6 million from $749.4 million. Rental income grew to $1.00 billion from $887.9 million, driven mainly by acquisitions, lease escalators and cash-basis operator receipts.

  2. What is the status of the Genesis Healthcare and Maplewood exposures?

    Genesis commenced Chapter 11 cases in July 2025 and continues to operate 31 facilities under a master lease; it made all required rent and interest payments through year-end 2025, and a sale to 101 W State Street Holdings, LLC was approved by the bankruptcy court on January 26, 2026, with closing not expected for 90-120 days. Maplewood's master lease and revolver were restructured on December 11, 2025, with 2026 contractual rent of $76.5 million and a Maplewood Revolver amortized cost of $263.6 million on non-accrual status.

  3. What are the company's main debt maturities and refinancing actions?

    The next senior note maturity is $700 million of 4.50% senior notes due April 2027. During 2025 the company repaid $400 million of 4.50% notes in January, redeemed $600.0 million of 5.250% notes, repaid the $428.5 million 2026 Term Loan, and issued $600 million of 5.200% senior notes due 2030.

  4. What dividend has the Board declared and how is it funded?

    Quarterly dividends paid in 2025 totaled $2.68 per share, and on January 29, 2026 the Board declared a $0.67 per share dividend payable February 17, 2026 to holders of record on February 9, 2026. The filing notes that dividends are subject to Board approval and that there are no assurances of future dividend payments.

  5. What regulatory developments could affect operators' ability to pay rent?

    The July 2025 OBBBA enacted an estimated $920 billion in Medicaid cuts over the next decade. CMS's SNF minimum staffing rule was repealed through an interim final rule on December 3, 2025, and the ownership-disclosure requirement for REIT-leased SNFs was suspended indefinitely in December 2025. The filing also cites a fiscal year 2026 Medicare Part A projected increase of $1.16 billion, or 3.2%.